Ginsenoside compound K exerts antitumour effects in renal cell carcinoma via regulation of ROS and lncRNA THOR

Renal cell carcinoma (RCC) is a common type of kidney cancer that lacks effective therapeutic options. Ginsenoside compound K (CK), an active metabolite of ginsenosides, has been reported to induce apoptosis in various types of cancer cells. However, the effects of CK in RCC remain to be elucidated....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuqiu, Ye, Haihong, Gong, Fanger, Mao, Suming, Li, Cong, Xu, Bin, Ren, Yu, Yu, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905530/
https://www.ncbi.nlm.nih.gov/pubmed/33649829
http://dx.doi.org/10.3892/or.2021.7989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905530/
https://www.ncbi.nlm.nih.gov/pubmed/33649829
http://dx.doi.org/10.3892/or.2021.7989

Ejemplares similares